Versartis Inc (VSAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VSAR | SLGL | MGX | ||
| Company | Versartis Inc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.22 | 72.61 | 1.2000 | ||
| High | 1.30 | 76.00 | 1.2400 | ||
| Low | 1.18 | 66.15 | 1.1900 | ||
| Last | 1.19 | 68.81 | 1.1900 | ||
| Change | -0.02 | -3.76 | -0.0200 | ||
| Percent Change | -1.65% | -5.18% | -1.65% | ||
| Volume | 349,900 | 147,700 | 78,100 | ||
| 20-Day Average Volume | 237,635 | 65,055 | 136,400 | ||
| Previous | 1.21 | 72.57 | 1.2100 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.37 | 80.47 | 1.2183 | ||
| 20-Day Raw Stochastic | 10.87% | 10.80% | 12.50% | ||
| 20-Day Relative Strength | 32.11 | 41.10 | 44.10 | ||
| Weighted Alpha | -62.20 | +93.95 | -34.06 | ||
| Today's Opinion | N/A | 24% Buy | 100% Sell | ||
| Yesterday's Opinion | N/A | 24% Buy | 96% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.46% since 10/08/18 | -11.48% since 08/21/26 | -3.25% since 08/21/26 | ||
| Low | 1.14 on 10/12/18 | 66.15 on 08/28/26 | 1.1900 on 08/28/26 | ||
| High | 1.36 on 10/10/18 | 82.19 on 08/25/26 | 1.2500 on 08/25/26 | ||
| 1-Month | |||||
| %Chg | -17.93% since 09/14/18 | -17.17% since 07/28/26 | -1.65% since 07/28/26 | ||
| Low | 1.14 on 10/12/18 | 66.15 on 08/28/26 | 1.1800 on 08/11/26 | ||
| High | 1.60 on 09/27/18 | 90.79 on 08/14/26 | 1.2600 on 08/21/26 | ||
| 3-Month | |||||
| %Chg | -41.95% since 07/13/18 | -8.59% since 05/28/26 | -15.00% since 05/28/26 | ||
| Low | 1.14 on 10/12/18 | 66.00 on 06/01/26 | 1.1300 on 06/17/26 | ||
| High | 2.10 on 07/24/18 | 93.74 on 07/22/26 | 1.3999 on 05/29/26 | ||
| 6-Month | |||||
| %Chg | -26.77% since 04/13/18 | -24.95% since 02/27/26 | -21.71% since 02/27/26 | ||
| Low | 1.14 on 10/12/18 | 61.92 on 03/23/26 | 1.1300 on 06/17/26 | ||
| High | 2.55 on 06/18/18 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 43,126 | 193,349 | 44,955 | ||
| Shares Outstanding, K | 36,240 | 2,810 | 37,777 | ||
| Annual Sales, $M | 40,000,000 | 19,390,000 | 25,210,000 | ||
| Annual Net Income, $M | -84,980,000 | -6,130,000 | -87,870,000 | ||
| Last Qtr Sales, $M | N/A | 590,000 | 1,250,000 | ||
| Last Qtr Income, $M | N/A | -3,680,000 | -23,060,000 | ||
| 60-Month Beta | 1.94 | 1.12 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 10/26/17 | -1.13 on 08/20/26 | -0.73 on 08/10/26 | ||
| Latest Earnings Date | 10/25/18 | 11/19/26 | 11/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||